Megestrol - Daewon Pharmaceutical

Drug Profile

Megestrol - Daewon Pharmaceutical

Alternative Names: DW-ES(A); DW-ES(B)

Latest Information Update: 23 May 2016

Price : $50

At a glance

  • Originator Daewon Pharmaceutical
  • Class Antiandrogens; Antineoplastics; Pregnadienes; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Anorexia; Cachexia

Most Recent Events

  • 23 May 2016 Chemical information added
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top